These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 31796165)
21. Emerging trends in the novel drug delivery approaches for the treatment of lung cancer. Sharma P; Mehta M; Dhanjal DS; Kaur S; Gupta G; Singh H; Thangavelu L; Rajeshkumar S; Tambuwala M; Bakshi HA; Chellappan DK; Dua K; Satija S Chem Biol Interact; 2019 Aug; 309():108720. PubMed ID: 31226287 [TBL] [Abstract][Full Text] [Related]
22. Nanotargeted agents: an emerging therapeutic strategy for breast cancer. Du M; Ouyang Y; Meng F; Ma Q; Liu H; Zhuang Y; Pang M; Cai T; Cai Y Nanomedicine (Lond); 2019 Jul; 14(13):1771-1786. PubMed ID: 31298065 [TBL] [Abstract][Full Text] [Related]
23. Biopolymeric alginate-chitosan nanoparticles as drug delivery carriers for cancer therapy. Bhunchu S; Rojsitthisak P Pharmazie; 2014 Aug; 69(8):563-70. PubMed ID: 25158565 [TBL] [Abstract][Full Text] [Related]
24. Lipid-based drug delivery systems for cancer treatment. Arias JL; Clares B; Morales ME; Gallardo V; Ruiz MA Curr Drug Targets; 2011 Jul; 12(8):1151-65. PubMed ID: 21443475 [TBL] [Abstract][Full Text] [Related]
25. Nanoparticulate carriers: an emerging tool for breast cancer therapy. Tharkar P; Madani AU; Lasham A; Shelling AN; Al-Kassas R J Drug Target; 2015 Feb; 23(2):97-108. PubMed ID: 25230853 [TBL] [Abstract][Full Text] [Related]
26. RNA Nanotechnology-Mediated Cancer Immunotherapy. Lin YX; Wang Y; Blake S; Yu M; Mei L; Wang H; Shi J Theranostics; 2020; 10(1):281-299. PubMed ID: 31903120 [TBL] [Abstract][Full Text] [Related]
27. Impact of nanotechnology on drug delivery. Farokhzad OC; Langer R ACS Nano; 2009 Jan; 3(1):16-20. PubMed ID: 19206243 [TBL] [Abstract][Full Text] [Related]
28. Lipid-coated polymeric nanoparticles for cancer drug delivery. Krishnamurthy S; Vaiyapuri R; Zhang L; Chan JM Biomater Sci; 2015 Jul; 3(7):923-36. PubMed ID: 26221931 [TBL] [Abstract][Full Text] [Related]
31. Next-generation nanotheranostics targeting cancer stem cells. Reda A; Hosseiny S; El-Sherbiny IM Nanomedicine (Lond); 2019 Sep; 14(18):2487-2514. PubMed ID: 31490100 [TBL] [Abstract][Full Text] [Related]
32. Magnetic nanoparticles based cancer therapy: current status and applications. Zhang H; Liu XL; Zhang YF; Gao F; Li GL; He Y; Peng ML; Fan HM Sci China Life Sci; 2018 Apr; 61(4):400-414. PubMed ID: 29675551 [TBL] [Abstract][Full Text] [Related]
33. Nanocarriers for cancer-targeted drug delivery. Kumari P; Ghosh B; Biswas S J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298 [TBL] [Abstract][Full Text] [Related]
34. From therapeutic monoclonal antibodies to therapeutic vaccines for cancer. Berinstein NL Hum Vaccin; 2009 Jun; 5(6):364-7. PubMed ID: 19694082 [No Abstract] [Full Text] [Related]
36. Nanotechnology-based drug delivery for cancer. Jain KK Technol Cancer Res Treat; 2005 Aug; 4(4):407-16. PubMed ID: 16029059 [TBL] [Abstract][Full Text] [Related]
37. An Appraisal on Various Methods of Nano Particulate Formulations. Dhiman B; Divtrannum ; Dhiman A; Saini S Pharm Nanotechnol; 2017; 5(4):255-262. PubMed ID: 29119943 [TBL] [Abstract][Full Text] [Related]
38. Can a nanoparticle that mimics Salmonella effectively combat tumor chemotherapy resistance? Mercado-Lubo R; McCormick BA Nanomedicine (Lond); 2017 Apr; 12(7):705-710. PubMed ID: 28322607 [No Abstract] [Full Text] [Related]